Neuroblastoma-specific mesenchymal transcriptional signature was also repressed after BAF disruption in neuroblastoma cells (Fig. 3H), involving the epigenetic repression of key regulators of the mesenchymal phenotype, such as SNAI2, CDH11, CDH2, LOXL2 and NOTCH2 (Fig. 3C and I, Fig. S5C). The gene discussed is CDH11; the disease is neuroblastoma.